Solutions

Online Inquiry

Global Services. (Creative Biolabs Authorized)

TAC-T Product Phenotype & Quality Analysis Service

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

The clinical advancement of T-cell antigen coupler (TAC) immunotherapies is often hindered by challenges in accurately characterizing complex cellular phenotypes, ensuring batch-to-batch consistency, and capturing rare but critical cell subsets for rigorous quality control. Creative Biolabs' dedicated TAC-T Product Phenotype & Quality Analysis Service addresses these hurdles by delivering a comprehensive analytical platform. This service integrates high-resolution polychromatic flow cytometry, multi-parametric functional potency assays, and specialized microfluidic isolation techniques. By providing deep insights into TAC expression, differentiation states, and functional integrity, we empower you to validate therapeutic potency, enhance product durability, and meet stringent regulatory standards with confidence.

Introduction

The T-cell antigen coupler (TAC) is an innovative synthetic receptor that engages the endogenous TCR/CD3 machinery, harnessing its natural signaling precision and intrinsic safeguards against antigen-independent activation. Here, we detail the preclinical evaluation of TAC01-CLDN18.2, an investigational autologous T cell product directed against Claudin 18.2, a target antigen overexpressed in gastric, gastroesophageal, and pancreatic adenocarcinomas. Our data demonstrate that CLDN18.2-specific TAC-T cells mediate exact antigen discrimination, sustained tumor eradication in diverse preclinical models, and a promising therapeutic window absent of on-target, off-tumor activity, thereby providing a strong rationale for their clinical advancement in CLDN18.2-positive cancers.

Fig.1 Characterization and specificity profile of the CLDN18.2-TAC receptor. (OA Literature) Fig.1 Specificity and phenotypic attributes of the CLDN18.2-targeting TAC receptor.¹

TAC-T Product Phenotype & Quality Analysis Service at Creative Biolabs

TAC-T technology constitutes a significant advancement in replicating natural T-cell receptor (TCR) signaling, offering more precise activation dynamics compared to conventional CAR-T systems. This inherent complexity demands equally sophisticated analytical characterization. Our approach leverages centrifugal microfluidics and hydrodynamic cell entrapment to reliably isolate and analyze low frequency cell subsets. Crucially, comprehensive profiling of TAC-T cell differentiation states and functional potential serves as the key prognostic indicator of sustained in vivo efficacy, particularly in the context of solid tumor applications.

What We Can Offer

Our comprehensive phenotyping panel employs high-parameter flow cytometry to dissect the cellular identity, fitness, and safety of your TAC-T product. This detailed analysis directly informs critical quality attributes for potency, persistence, and clinical safety.

Featured services of TAC-T product phenotype & quality analysis service at Creative Biolabs. (Creative Biolabs Original)

Our Service Process

Required Starting Materials: To begin the service, you need to provide cryopreserved, engineered TAC-T cells as starting material, together with detailed TAC construct schematics or vector sequences necessary for the precise design of primers and probes.

Key Steps:

Workflow of TAC-T product phenotype & quality analysis service at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables: Upon project completion, you will be provided with a comprehensive Analytical Characterization Report. This report encompasses raw flow cytometry data files, detailed statistical analyses delineating key T cell subpopulations, and high-resolution graphical representations of cytotoxicity kinetics.

Key Advantages

Targeted Phenotype Analysis: Bespoke flow cytometry panels engineered to precisely quantify TAC receptor expression and co-receptor interactions.
Expression System Optimization: Codon usage refinement and genomic integration studies to enhance receptor expression while minimizing process variability.
Dedicated Operational Infrastructure: High-throughput processing and controlled environments designed to maintain cellular viability and functional integrity.

FAQs

Q1: What distinguishes TAC-T phenotype analysis from standard CAR-T QC?

A1: TAC-T cells require monitoring of the TCR/CD3 complex stability and co-receptor signaling, which is more complex than simple CAR expression. Our service includes specific assays to ensure the TAC construct is properly integrated with the endogenous T-cell machinery.

Q2: Can you analyze TAC-T products for solid tumor targets?

A2: Yes, we specialize in markers relevant to solid tumor infiltration, such as chemokine receptor expression (CXCR3, CCR5) and resistance to immunosuppressive signals in the tumor microenvironment.

Q3: How do you ensure the precision of exhaustion marker quantification?

A3: We use standardized beads and multi-color flow cytometry panels validated against internal reference standards to ensure that PD-1 or TIM-3 levels are absolute and comparable across batches.

Why Choose Us?

Choose our service for our proprietary phenotype-focused analysis platform. Built on two decades of T-cell expertise, it goes beyond standard QC by mimicking physiological activation, employing our internal benchmarks to precisely define memory and effector subsets, ensuring your product demonstrates superior persistence and potency for regulatory differentiation.

Customer Reviews

"The adoption of Creative Biolabs' standardized TAC-T analysis platform has markedly enhanced the reliability of our potency evaluations. Their results demonstrated excellent correlation with our internal benchmarks while delivering a far more granular dissection of critical functional T-cell subsets."

— Dr. M*l Wg.

"Integrating Creative Biolabs' TAC-T analysis into our development workflow enabled the detection of rare, antigen-specific T-cell clones that conventional assays overlooked. Their high-resolution phenotyping was pivotal in refining our manufacturing process to achieve unprecedented batch consistency."

— Dr. Jn S*h.

"Creative Biolabs' comprehensive analytical service was instrumental in accelerating our candidate selection for in vivo studies. The exhaustive profiling of T-cell exhaustion and memory markers provided critical data to identify clones with superior long-term therapeutic potential."

— Prof. A**a Le.

How to contact us?

Creative Biolabs delivers a comprehensive analytical platform, bridging cell engineering and clinical readiness through advanced flow cytometry and validated functional assays. Our service ensures the critical quality attributes of potency, persistence, and purity for T-cell immunotherapies are rigorously characterized.

Please contact our team for detailed information and to initiate a project consultation.

Reference

Xu, Stacey X et al. "Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2-Positive Solid Tumors." Cancer immunology research vol. 13,1 (2025): 35-46. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.1158/2326-6066.cir-24-0138

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.